Use of tissue microarrays (TMA) in evaluating prognostic factors in 100 glioblastoma multiforme (GBM) patients

被引：0
|
作者：
Chiesa-Vottero, AG [1 ]
Prayson, RA [1 ]
Castilla, EA [1 ]
Hartke, M [1 ]
Rybicki, LA [1 ]
Tubbs, RR [1 ]
Vogelbaum, M [1 ]
Barnett, G [1 ]
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
LABORATORY INVESTIGATION | 2003年 / 83卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1319
引用
收藏
页码：289A / 289A
页数：1
相关论文
共 50 条
  • [41] PROGNOSTIC FACTORS INFLUENCING THE CLINICAL OUTCOMES OF GLIOBLASTOMA MULTIFORME
    Li Shouwei
    [J]. NEURO-ONCOLOGY, 2009, 11 (05) : 625 - 625
  • [42] Prognostic factors influencing clinical outcomes of glioblastoma multiforme
    Li Shou-Wei
    Qiu Xiao-guang
    Chen Bao-shi
    Zhang Wei
    Ren Huan
    Wang Zhong-cheng
    Jiang Tao
    [J]. CHINESE MEDICAL JOURNAL, 2009, 122 (11) : 1245 - 1249
  • [43] Multifocal glioblastoma multiforme: Prognostic factors and patterns of progression
    Showalter, Timothy N.
    Andrel, Jocelyn
    Andrews, David W.
    Curran, Walter J., Jr.
    Daskalakis, Constantine
    Werner-Wasik, Maria
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : 820 - 824
  • [44] Multifocal glioblastoma multiforme: Prognostic factors and patterns of progression
    Andrel, J.
    Showalter, T. N.
    Andrews, D. W.
    Curran, W. J.
    White, J. S.
    Daskalakis, C.
    Werner-Wasik, M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S247 - S247
  • [45] Recursive partitioning analysis of prognostic factors in glioblastoma multiforme (GBM) cases seen in Ottawa over a period of 10 years
    Agboola, O
    McNulty, M
    Gertler, S
    [J]. RADIOTHERAPY AND ONCOLOGY, 2005, 76 : S42 - S43
  • [46] Levetiracetam (LEV) use in glioblastoma multiforme (GBM) patients: A single institution retrospective review of 102 patients with seizures
    Stevens, G. H. J.
    Lupica, K.
    Peereboom, D. M.
    Suh, J. H.
    Cohen, B. H.
    Vogelbaum, M. A.
    Toms, S. A.
    Barnett, G. H.
    [J]. NEURO-ONCOLOGY, 2006, 8 (04) : 304 - 304
  • [47] Identifying factors to predict benefit from bevacizumab in progressive glioblastoma multiforme (GBM).
    Gleeson, Jack Patrick
    Alhusaini, Abdullah
    O'Halloran, Philip
    Harrold, Emily
    Keegan, Niamh M.
    Karadawi, Nabeeha Eltag
    Mammadov, Emin
    Kamel, Dalia
    Egan, Keith
    Molloy, Susan
    Hennessy, Bryan T.
    Breathnach, Oscar S.
    Grogan, William
    Morris, Patrick G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [48] DEVELOPMENT OF A NOVEL BURDEN SURVEY FOR CAREGIVERS OF GLIOBLASTOMA MULTIFORME (GBM) PATIENTS
    Au, Trang
    Bauer, Hillevi
    Ma, Junjie
    Nelson, Ryan
    Watanabe, Alexandre
    Singh, Prianka
    Korytowsky, Beata
    Wilson, Elizabeth
    Willmarth, Nicole
    Cohen, Adam
    Colman, Howard
    Stenehjem, David
    Brixner, Diana
    [J]. NEURO-ONCOLOGY, 2017, 19 : 110 - 110
  • [49] Outcomes of symptomatic compared to asymptomatic recurrences in patients with glioblastoma multiforme (GBM)
    Amini, Arya
    Altoos, Basel
    Karam, Sana D.
    Waxweiler, Timothy V.
    Rusthoven, Chad G.
    Gaspar, Laurie E.
    Honce, Justin M.
    Damek, Denise M.
    Ney, Douglas E.
    Ormond, D. Ryan
    Lillehei, Kevin O.
    Chen, Changhu
    Kavanagh, Brian D.
    Liu, Arthur K.
    [J]. JOURNAL OF RADIATION ONCOLOGY, 2016, 5 (01) : 33 - 39
  • [50] Evaluation of Symptomatic Versus Asymptomatic Recurrences in Patients With Glioblastoma Multiforme (GBM)
    Altoos, B.
    Amini, A.
    Karam, S.
    Gaspar, L. E.
    Rusthoven, C. G.
    Waxweiler, T. V.
    Honce, J.
    Damek, D. M.
    Ney, D. E.
    Ormond, D. R.
    Lillehei, K. O.
    Kavanagh, B. D.
    Liu, A. K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E117 - E117
12345